Moncef Slaoui served as Chief Advisor for the US government’s COVID-19 vaccine development effort, Operation Warp Speed (OPWASP).
Slaoui previously spent nearly 30 years at GlaxoSmithKline (GSK), most recently as Chairman of Global Vaccines, and sat on GSK’s board from 2006 until his retirement.
He also was on Moderna’s Board of Directors between 2017 and 2020 the start of Operation Warp Speed in 2020.
Sign up to our newsletter to receive the latest industry news, and trends.